These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18334241)

  • 1. Chronic kidney disease risk reduction in a Hispanic population through pharmacist-based disease-state management.
    Leal S; Soto M
    Adv Chronic Kidney Dis; 2008 Apr; 15(2):162-7. PubMed ID: 18334241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment for chronic kidney disease service in high-risk patients at community health clinics.
    Patel HR; Pruchnicki MC; Hall LE
    Ann Pharmacother; 2005 Jan; 39(1):22-7. PubMed ID: 15546945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the management of chronic kidney disease in Uruguay: a National Renal Healthcare Program.
    Schwedt E; Solá L; Ríos PG; Mazzuchi N;
    Nephron Clin Pract; 2010; 114(1):c47-59. PubMed ID: 19816043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of a community pharmacy-based rural asthma management service.
    Saini B; Filipovska J; Bosnic-Anticevich S; Taylor S; Krass I; Armour C
    Aust J Rural Health; 2008 Apr; 16(2):100-8. PubMed ID: 18318852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Providing diabetes education and care to underserved patients in a collaborative practice at a utah community health center.
    Shane-McWhorter L; Oderda GM
    Pharmacotherapy; 2005 Jan; 25(1):96-109. PubMed ID: 15767225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).
    McLean DL; McAlister FA; Johnson JA; King KM; Makowsky MJ; Jones CA; Tsuyuki RT;
    Arch Intern Med; 2008 Nov; 168(21):2355-61. PubMed ID: 19029501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial.
    Cortés-Sanabria L; Cabrera-Pivaral CE; Cueto-Manzano AM; Rojas-Campos E; Barragán G; Hernández-Anaya M; Martínez-Ramírez HR
    Am J Kidney Dis; 2008 May; 51(5):777-88. PubMed ID: 18436088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    Whaley-Connell AT; Sowers JR; Stevens LA; McFarlane SI; Shlipak MG; Norris KC; Chen SC; Qiu Y; Wang C; Li S; Vassalotti JA; Collins AJ;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S13-20. PubMed ID: 18359403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease management in chronic kidney disease.
    Rastogi A; Linden A; Nissenson AR
    Adv Chronic Kidney Dis; 2008 Jan; 15(1):19-28. PubMed ID: 18155106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist roles in the management of patients with type 2 diabetes.
    Sisson E; Kuhn C
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S41-5. PubMed ID: 19801364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study.
    Belaiche S; Romanet T; Allenet B; Calop J; Zaoui P
    J Nephrol; 2012; 25(5):782-8. PubMed ID: 22322820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects.
    Mangum SA; Kraenow KR; Narducci WA
    J Am Pharm Assoc (Wash); 2003; 43(1):50-5. PubMed ID: 12585751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney early evaluation program: a community-based screening approach to address disparities in chronic kidney disease.
    Vassalotti JA; Li S; McCullough PA; Bakris GL
    Semin Nephrol; 2010 Jan; 30(1):66-73. PubMed ID: 20116650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participant follow-up in the Kidney Early Evaluation Program (KEEP) after initial detection.
    Collins AJ; Li S; Chen SC; Vassalotti JA
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S69-76. PubMed ID: 18359410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a self-management package for people with diabetes at risk of chronic kidney disease (CKD).
    Thomas N; Bryar R; Makanjuola D
    J Ren Care; 2008 Sep; 34(3):151-8. PubMed ID: 18786082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
    Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
    Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmaceutical care of patients with diabetes mellitus and its relationship to clinical pharmacy].
    Vlcek J; Malý J; Dosedel M
    Vnitr Lek; 2009 Apr; 55(4):384-8. PubMed ID: 19449755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.